stockrowMcKesson Corporation
MCK Healthcare Medical Distribution
McKesson Corporation’s revenue for fiscal 2026 (year ended March 2026) was $403.4 billion, up 12.4% from fiscal 2025.
- Revenue
- +7.57%
- EPS
- +17.0%
- Free cash flow
- +32.5%
- Total debt
- +7.08%
Quarter to September 2026, against a year earlier
Follow MCK
Alert me
McKesson Corporation (MCK) Net income
McKesson Corporation's net income for fiscal 2026 was $5.1B, up 46.5% from $3.5B in fiscal 2025. Over the twelve months to 30 September 2026 it was $5.4B. Over the past ten years it has ranged from −$4.3B (fiscal 2021) to $5.2B (fiscal 2017); the current reading is higher than 92% of that period. McKesson Corporation ranks 1st of 12 Medical Distribution companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2026 | $5.1B | 46.48% |
| FY2025 | $3.5B | 10.16% |
| FY2024 | $3.2B | (15.10%) |
| FY2023 | $3.7B | 189.20% |
| FY2022 | $1.3B | — |
| FY2021 | −$4.3B | — |
| FY2020 | $1.1B | 339.22% |
| FY2019 | $255.0M | (14.14%) |
| FY2018 | $297.0M | (94.24%) |
| FY2017 | $5.2B | 123.07% |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Sep 2026 | $1.3B | 25.58% |
| Jun 2026 | $1.0B | (44.37%) |
| Mar 2026 | $1.9B | 48.40% |
| Dec 2025 | $1.3B | 7.48% |
| 43 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| MCK McKesson Corporation | $5.4B |
| COR Cencora, Inc. compare | $3.5B |
| CAH Cardinal Health, Inc. compare | $1.8B |
| HSIC Henry Schein, Inc. compare | $443.0M |
| AHG Akso Health Group Sponsored ADR compare | $15.6M |
| YI 111, Inc. Sponsored ADR compare | −$3.2M |
| COSM Cosmos Health Inc. compare | −$24.4M |
| FOCL FocalTherics compare | −$39.0M |
| ACH Accendra Health, Inc. compare | −$302.1M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on MCK
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement